Biotest Management
Management criteria checks 2/4
We currently do not have sufficient information about the CEO.
Key information
Peter Janssen
Chief executive officer
€926.0k
Total compensation
| CEO salary percentage | 47.5% |
| CEO tenure | 2.3yrs |
| CEO ownership | n/a |
| Management average tenure | 2.6yrs |
| Board average tenure | 2.6yrs |
Recent management updates
Recent updates
CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Sep 30 2024 | n/a | n/a | €69m |
| Jun 30 2024 | n/a | n/a | €164m |
| Mar 31 2024 | n/a | n/a | €177m |
| Dec 31 2023 | €926k | €440k | €127m |
| Sep 30 2023 | n/a | n/a | €91m |
| Jun 30 2023 | n/a | n/a | -€10m |
| Mar 31 2023 | n/a | n/a | -€47m |
| Dec 31 2022 | €333k | €147k | -€32m |
Compensation vs Market: Peter's total compensation ($USD966.19K) is below average for companies of similar size in the German market ($USD1.58M).
Compensation vs Earnings: Peter's compensation has increased by more than 20% whilst company earnings have fallen more than 20% in the past year.
CEO
Peter Janssen (56 yo)
2.3yrs
Tenure
€926,000
Compensation
Mr. Peter Janssen serves as Member of Management Board for Biotest Aktiengesellschaft since September 1, 2022 and served as its Chief Operating Officer since September 2022 until January 2024. He has been...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| CEO & Chairman of the Board of Management | 2.3yrs | €926.00k | no data | |
| Member of Supervisory Board | 2.9yrs | €44.00k | no data | |
| Chief Financial Officer | less than a year | no data | no data | |
| Head of Investor Relations | no data | no data | no data | |
| Head of Corporate HR | 9.3yrs | no data | no data |
2.6yrs
Average Tenure
Experienced Management: BIO3's management team is considered experienced (2.6 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Member of Supervisory Board | 2.6yrs | €44.00k | no data | |
| Member of Supervisory Board | 1.6yrs | €29.00k | no data | |
| Chairman of the Supervisory Board | 2.6yrs | €132.00k | no data | |
| Member of Supervisory Board | 2.5yrs | €44.00k | no data | |
| Employee Representative Member of Supervisory Board | 13.3yrs | €44.00k | no data |
2.6yrs
Average Tenure
64.5yo
Average Age
Experienced Board: BIO3's board of directors are not considered experienced ( 2.6 years average tenure), which suggests a new board.
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/23 15:43 |
| End of Day Share Price | 2024/12/20 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Biotest Aktiengesellschaft is covered by 11 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Volker Braun | Commerzbank AG |
| Martin Possienke | GSN North America |
| Torben Teichler | Hauck Aufhäuser Investment Banking |